Search for: "State v. Mannering"
Results 141 - 160
of 18,988
Sorted by Relevance
|
Sort by Date
13 May 2012, 9:00 pm
State and Jorgenson v. [read post]
2 Oct 2014, 2:48 am
[1] R (Barclay) v Secretary of State for Justice & Ors [2009] UKSC 9 [2] R (Barclay & Anor) v Secretary of State for Justice and Lord Chancellor, The Committee for the Affairs of Jersey and Guernsey and Her Ma [read post]
21 Jan 2020, 7:21 am
State v. [read post]
19 Mar 2007, 10:35 am
Appellant stated he understood and entered a plea of guilty. [read post]
29 Aug 2017, 12:00 am
STATE V. [read post]
1 Aug 2015, 9:06 am
This was the situation in Kimminau v. [read post]
6 Mar 2014, 6:47 am
State v. [read post]
17 Feb 2007, 7:14 am
For the closely regulated industry exception to apply, then the state liquor control authorities have to be the ones conducting the sweeps, not law enforcement in a manner that created an inference of harassment and discrimination against patrons. [read post]
27 Mar 2017, 6:53 pm
The court in this case also used the analysis in Silver v. [read post]
27 Mar 2017, 6:53 pm
The court in this case also used the analysis in Silver v. [read post]
11 Jun 2019, 7:00 am
Most states have modeled their law after the South Dakota law analyzed in South Dakota v. [read post]
26 Nov 2014, 7:28 am
Johnson and Davis v. [read post]
7 Jul 2013, 11:33 pm
Supreme Court explained in United States v. [read post]
11 May 2012, 4:11 am
The case of Nashiri v. [read post]
26 Jun 2023, 4:30 am
On Friday, in United States v. [read post]
29 Dec 2016, 4:43 pm
See, e.g., Langfitt v. [read post]
29 Dec 2016, 4:43 pm
See, e.g., Langfitt v. [read post]
6 Jul 2022, 7:11 am
Supreme Court handed down its decision in West Virginia v. [read post]
3 Mar 2008, 7:27 am
" Sansone v. [read post]
12 Jan 2007, 6:20 pm
Biogen IDEC, decided just a month after Merck in the District of Maryland, the district court interpreted Merck's holding in the broadest possible manner, dismissing Classen's claims against Biogen IDEC ("Biogen") and GlaxoSmithKline ("GSK") when the defendants successfully argued that their allegedly infringing acts of research tool use fell within the safe harbor provision of 271(e)(1) as construed in Lilly and Merck. n89footnote 89 states: Classen… [read post]
